Goldman Sachs Research Summary (APR 5, 2007)
Tweet
Share
E-mailGet Alerts MU Hot Sheet
Price: $853.20 --0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.8%
Revenue Growth %: +345.1%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.8%
Revenue Growth %: +345.1%
Join SI Premium – FREE
From 247WallSt
This is one of the last research summaries that Goldman Sachs will be issuing before the earnings deluge comes.
The first and foremost call was a Downgrade on Micron (NYSE: MU) to a Sell from a neutral. MU is still up pre-market after wider losses, but it was up much more last night. It sees 17% downside to the stock.
Goldman is making a switch in its investment manager coverage: It has raised Janus (NYSE: JNS) from Sell to Neutral, and downgraded Calamos (Nasdaq: CLMS) from a Neutral down to a Sell.
Some of its INCREASED earnings estimates are on the following: Gilead (Nasdaq: GILD), OSI Pharma (Nasdaq: OSIP), Packaging Corp of America (NYSE: PKG), Research in Motiuon (Nasdaq: RIMM), Smurfit-Stone Container (Nasdaq: SSCC), Yahoo! (Nasdaq: YHOO).
Some of Goldman's DECREASED earnings estimates are in the following: Affiliated Managers Group (NYSE: AMG), AllianceBernstein (NYSE: AB), Biogen-Idec (Nasdaq: BIIB), BlackRock (NYSE: BLK), Calamos (Nasdaq: CLMS), Bowater (NYSE: BOW), Cohen & Steers (NYSE: CNS), Federated Investors (NYSE: FII), Franklin Resources (NYSE: BEN), GAMCO Investors (NYSE: GBL), Legg Mason (NYSE: LM), Huntington Bancshares (HBAN), MedImmune (MEDI), T. Rowe PRice (Nasdaq: TROW), ViroPharma (Nasdaq: VPHM), Waddell & Reed (NYSE: WDR), Nuveen (NYSE: JNC), Eaton Vance (NYSE: EV).
Yahoo! (Nasdaq: YHOO) estimates were raised by 2% revenues and 3% EBITDA respectively for 2007; price target raised from $31.50 to $35.00.
Maintained buy and positive ratings on Marvell Tech (Nasdaq: MRVL), BEA Systems (Nasdaq: BEAS), and Research in Motion (Nasdaq: RIMM). On Micrchip Tech (Nasdaq: MCHP) Goldman said it has some positive takeaways from the company's competitors and customers, but it is not yet making any changes to its Neutral ratings.
Jon C. Ogg
For more market insight go to http://www.247wallst.com
This is one of the last research summaries that Goldman Sachs will be issuing before the earnings deluge comes.
The first and foremost call was a Downgrade on Micron (NYSE: MU) to a Sell from a neutral. MU is still up pre-market after wider losses, but it was up much more last night. It sees 17% downside to the stock.
Goldman is making a switch in its investment manager coverage: It has raised Janus (NYSE: JNS) from Sell to Neutral, and downgraded Calamos (Nasdaq: CLMS) from a Neutral down to a Sell.
Some of its INCREASED earnings estimates are on the following: Gilead (Nasdaq: GILD), OSI Pharma (Nasdaq: OSIP), Packaging Corp of America (NYSE: PKG), Research in Motiuon (Nasdaq: RIMM), Smurfit-Stone Container (Nasdaq: SSCC), Yahoo! (Nasdaq: YHOO).
Some of Goldman's DECREASED earnings estimates are in the following: Affiliated Managers Group (NYSE: AMG), AllianceBernstein (NYSE: AB), Biogen-Idec (Nasdaq: BIIB), BlackRock (NYSE: BLK), Calamos (Nasdaq: CLMS), Bowater (NYSE: BOW), Cohen & Steers (NYSE: CNS), Federated Investors (NYSE: FII), Franklin Resources (NYSE: BEN), GAMCO Investors (NYSE: GBL), Legg Mason (NYSE: LM), Huntington Bancshares (HBAN), MedImmune (MEDI), T. Rowe PRice (Nasdaq: TROW), ViroPharma (Nasdaq: VPHM), Waddell & Reed (NYSE: WDR), Nuveen (NYSE: JNC), Eaton Vance (NYSE: EV).
Yahoo! (Nasdaq: YHOO) estimates were raised by 2% revenues and 3% EBITDA respectively for 2007; price target raised from $31.50 to $35.00.
Maintained buy and positive ratings on Marvell Tech (Nasdaq: MRVL), BEA Systems (Nasdaq: BEAS), and Research in Motion (Nasdaq: RIMM). On Micrchip Tech (Nasdaq: MCHP) Goldman said it has some positive takeaways from the company's competitors and customers, but it is not yet making any changes to its Neutral ratings.
Jon C. Ogg
For more market insight go to http://www.247wallst.com
You May Also Be Interested In
- BlackRock (BLK) PT Raised to $1,320 at UBS on 'Near Flawless' Quarter
- Truist cuts Lululemon to sell, sees structural headwinds and nearly 20% downside
- BlackRock (BLK) PT Raised to $1,300 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
